Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa-Reference-Cited by-同舟云学术

Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa

Published:2018-07-24 Issue:12 Volume:41 Page:1343-1353
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Onoya Dorina^ORCID,Hirasen Kamban,van den Berg Liudmyla,Miot Jacqui,Long Lawrence C.,Fox Matthew P.

Funder

USAID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/article/10.1007/s40264-018-0698-3/fulltext.html

Reference38 articles.

1. National Department of Health (South Africa). National Department of Health annual report 2016/2017. Pretoria: National Department of Health; 2017.

2. UNAIDS. Global AIDS update 2017. UNAIDS; 2017.

3. Johnson LF, Dorrington RE, Moolla H. Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. S Afr J HIV Med. 2017;18(1):a694.

4. Estill J, et al. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study. Lancet HIV. 2016;3(3):e132–9.

5. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, Mathee S, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. Aids. 2010;24(4):563–72.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation of adverse drug events in different settings in Africa: a systematic review;European Journal of Medical Research;2024-06-16

2. Evaluation of Adverse Drug Events in Patients on Anti-Retroviral Therapy Regimen at Omdurman Voluntary Counselling and Testing and Anti-Retroviral Therapy Center in Sudan – A Cross-Sectional Study;HIV/AIDS - Research and Palliative Care;2024-04

3. Understanding the role of religious beliefs in adherence to antiretroviral therapy among Pentecostal Christians living with HIV in sub-Saharan Africa: a scoping review;BMC Public Health;2023-09-11

4. Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing;Viruses;2023-06-27

5. Embracing the Changing Needs for Pharmacovigilance in Africa;Pharmacovigilance - Volume 2;2023-02-15